Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Plasmalogens as biomarkers and therapeutic targets.
Journal: Journal of lipid research
Published: July 17, 2025
Meta-analysis of niacin and NAD metabolite treatment in infectious disease animal studies suggests benefit but requires confirmation in clinically relevant models.
Journal: Scientific reports
Published: October 20, 2024
Anti-PD-L1 therapy altered inflammation but not survival in a lethal murine hepatitis virus-1 pneumonia model.
Journal: Frontiers in immunology
Published: October 06, 2023
The complexity of nicotinamide adenine dinucleotide (NAD), hypoxic, and aryl hydrocarbon receptor cell signaling in chronic kidney disease.
Journal: Journal of translational medicine
Published: July 17, 2023
Inflammation and DKK1-induced AKT activation contribute to endothelial dysfunction following NR2F2 loss.
Journal: American journal of physiology. Lung cellular and molecular physiology
Published: April 11, 2023
Nicotinamide Antagonizes Lipopolysaccharide-Induced Hypoxic Cell Signals in Human Macrophages.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: July 28, 2022
RAGE pathway activation and function in chronic kidney disease and COVID-19.
Journal: Frontiers in medicine
Published: June 15, 2022
Aryl Hydrocarbon Receptor Mechanisms Affecting Chronic Kidney Disease.
Journal: Frontiers in pharmacology
Published: September 24, 2021
Anti-PD-L1 Therapy Does Not Improve Survival in a Murine Model of Lethal Staphylococcus aureus Pneumonia.
Journal: The Journal of infectious diseases
Published: March 08, 2021
Observation and Quantification of Eosinophil Motility.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: January 24, 2021
PD-1 immunobiology in glomerulonephritis and renal cell carcinoma.
Journal: BMC nephrology
Published: November 05, 2020
Last Updated: 09/26/2026